Embark: a phase 3 randomized study of enzalutamide orplacebo plus leuprolide acetateandenzalutamide monotherapy in high-risk biochemically recurrent prostate cancer
JOURNAL OF UROLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF UROLOGY(2023)